Risk-adapted Therapy for Primary Systemic (AL) Amyloidosis
Clinical trial NCT01527032 · COMPLETED
Trial details
- NCT number
- NCT01527032
- Sponsor
- FDA Office of Orphan Products Development
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-09-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.